Diet Drug Linked with MI, Stroke and Cardiac Death
Researchers found an increased risk of cardiovascular events including stroke, myocardial infarction and cardiac death among people taking the prescription diet drug, sibutramine (Meridia).
Sibutramine (Meridia) is a prescription diet drug approved by the FDA in 1997 for the management of obesity in conjunction with a reduced calorie diet. It is only indicated for individuals with an initial body mass index of at least 30 kg/m2, or at least 27 kg/m2 with other risk factors such as diabetes, high cholesterol, or controlled high blood pressure.
The labeling of Meridia currently recommends avoiding the use of it in patients with a history of coronary artery disease (heart disease), congestive heart failure (CHF), arrhythmias, or stroke.
Learn more about the benefits of exercise and How to Start an Exercise Program
Source: “Early Data Link Diet Drug to MI, Stroke, and Cardiac Death” from MedPage Today, November 2009
Bookmark this page
E-mail this story
Print this post
0 Responses to “Diet Drug Linked with MI, Stroke and Cardiac Death”